These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

569 related articles for article (PubMed ID: 18577983)

  • 1. Chemotherapy for muscle-invasive bladder cancer treated with definitive radiotherapy: persisting uncertainties.
    Choueiri TK; Raghavan D
    Nat Clin Pract Oncol; 2008 Aug; 5(8):444-54. PubMed ID: 18577983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conservative treatment of invasive bladder carcinoma by transurethral resection, protracted intravenous infusion chemotherapy, and hyperfractionated radiotherapy: long term results.
    Danesi DT; Arcangeli G; Cruciani E; Altavista P; Mecozzi A; Saracino B; Orefici F
    Cancer; 2004 Dec; 101(11):2540-8. PubMed ID: 15481058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bladder preservation: optimizing radiotherapy and integrated treatment strategies.
    Mak RH; Zietman AL; Heney NM; Kaufman DS; Shipley WU
    BJU Int; 2008 Nov; 102(9 Pt B):1345-53. PubMed ID: 19035903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bladder-sparing therapy for muscle-infiltrating bladder cancer.
    Pansadoro V; Emiliozzi P
    Nat Clin Pract Urol; 2008 Jul; 5(7):368-75. PubMed ID: 18560383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bladder preservation in selected patients with muscle-invasive bladder cancer by complete transurethral resection of the bladder plus systemic chemotherapy: long-term follow-up of a phase 2 nonrandomized comparative trial with radical cystectomy.
    Solsona E; Climent MA; Iborra I; Collado A; Rubio J; Ricós JV; Casanova J; Calatrava A; Monrós JL
    Eur Urol; 2009 Apr; 55(4):911-9. PubMed ID: 18722046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer.
    Lehmann J; Franzaring L; Thüroff J; Wellek S; Stöckle M
    BJU Int; 2006 Jan; 97(1):42-7. PubMed ID: 16336326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current status of radiation therapy and combined-modality treatment for bladder cancer.
    Rödel C
    Strahlenther Onkol; 2004 Nov; 180(11):701-9. PubMed ID: 15549188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcome of radiation-based conservation therapy for invasive bladder cancer.
    Chung PW; Bristow RG; Milosevic MF; Yi QL; Jewett MA; Warde PR; Catton CN; McLean M; Moore M; Tannock IF; Gospodarowicz MK
    Urol Oncol; 2007; 25(4):303-9. PubMed ID: 17628296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of bladder cancer trials in the Radiation Therapy Oncology Group.
    Shipley WU; Kaufman DS; Tester WJ; Pilepich MV; Sandler HM;
    Cancer; 2003 Apr; 97(8 Suppl):2115-9. PubMed ID: 12673704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I-II RTOG study (99-06) of patients with muscle-invasive bladder cancer undergoing transurethral surgery, paclitaxel, cisplatin, and twice-daily radiotherapy followed by selective bladder preservation or radical cystectomy and adjuvant chemotherapy.
    Kaufman DS; Winter KA; Shipley WU; Heney NM; Wallace HJ; Toonkel LM; Zietman AL; Tanguay S; Sandler HM
    Urology; 2009 Apr; 73(4):833-7. PubMed ID: 19100600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant chemotherapy in the management of muscle-invasive bladder cancer.
    Dreicer R
    Semin Urol Oncol; 2001 Aug; 19(3):180-5. PubMed ID: 11561985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of muscle invasive bladder cancer. Is there a role for neoadjuvant chemotherapy?
    Kuten A; Baz M; Rubinov R; Dale J; Haim N; Robinson E; Cohen Y
    Strahlenther Onkol; 1994 Sep; 170(9):524-30. PubMed ID: 7524174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integration of neoadjuvant and adjuvant chemotherapy and cystectomy in the treatment of muscle-invasive bladder cancer.
    Milowsky MI; Stadler WM; Bajorin DF
    BJU Int; 2008 Nov; 102(9 Pt B):1339-44. PubMed ID: 19035902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perioperative chemotherapy in muscle-invasive bladder cancer to enhance survival and/or as a strategy for bladder preservation.
    Sternberg CN
    Semin Oncol; 2007 Apr; 34(2):122-8. PubMed ID: 17382795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bladder-sparing, combined-modality approach for muscle-invasive bladder cancer: a multi-institutional, long-term experience.
    Perdonà S; Autorino R; Damiano R; De Sio M; Morrica B; Gallo L; Silvestro G; Farella A; De Placido S; Di Lorenzo G
    Cancer; 2008 Jan; 112(1):75-83. PubMed ID: 18008364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organ-sparing strategies in the management of invasive bladder cancer.
    Yafi FA; Cury FL; Kassouf W
    Expert Rev Anticancer Ther; 2009 Dec; 9(12):1765-75. PubMed ID: 19954288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can chemo-radiotherapy plus transurethral tumor resection make cystectomy unnecessary for invasive bladder cancer?
    Shipley WU; Kaufman DS; Heney NM
    Oncology (Williston Park); 1990 Jul; 4(7):25-32; discussion 32-4, 39. PubMed ID: 2143938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction cisplatin and fluorouracil-based chemotherapy followed by concurrent chemoradiation for muscle-invasive bladder cancer.
    Lin CC; Hsu CH; Cheng JC; Huang CY; Tsai YC; Hsu FM; Huang KH; Cheng AL; Pu YS
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):442-8. PubMed ID: 19307067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of superficial recurrences in an irradiated bladder after combined-modality organ-preserving therapy.
    Weiss C; Wittlinger M; Engehausen DG; Krause FS; Ott OJ; Dunst J; Sauer R; Rödel C
    Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1502-6. PubMed ID: 17935905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of patients who refuse cystectomy after receiving neoadjuvant chemotherapy for muscle-invasive bladder cancer.
    Herr HW
    Eur Urol; 2008 Jul; 54(1):126-32. PubMed ID: 18248875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.